Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitors.
Outeda-García M, Arca-Suárez J, Lence E, Rodriguez-Coello A, Maceiras R, Blanco-Martin T, Guijarro-Sánchez P, Gonzalez-Pinto L, Alonso-Garcia I, García-Pose A, Muras A, Rodriguez-Pallares S, Lasarte-Monterrubio C, Gonzalez-Bello C, Vázquez-Ucha JC, Bou G, Beceiro A. Outeda-García M, et al. Among authors: gonzalez pinto l. Antimicrob Agents Chemother. 2025 Jan 10:e0161424. doi: 10.1128/aac.01614-24. Online ahead of print. Antimicrob Agents Chemother. 2025. PMID: 39791889 Free article.
Activity and resistance mechanisms of the third generation tetracyclines tigecycline, eravacycline and omadacycline against nationwide Spanish collections of carbapenemase-producing Enterobacterales and Acinetobacter baumannii.
García P, Guijarro-Sánchez P, Lasarte-Monterrubio C, Muras A, Alonso-García I, Outeda-García M, Maceiras R, Fernández-López MDC, Rodríguez-Coello A, García-Pose A, Blanco-Martín T, González-Pinto L, Arca-Suárez J, Vázquez-Ucha JC, Bou G, Beceiro A; Spanish National Acinetobacter spp. 2020 Study Group and GEMARA-SEIMC/REIPI Enterobacterales Study Group. García P, et al. Among authors: gonzalez pinto l. Biomed Pharmacother. 2024 Dec;181:117666. doi: 10.1016/j.biopha.2024.117666. Epub 2024 Dec 2. Biomed Pharmacother. 2024. PMID: 39626376 Free article.
Mutant prevention concentrations, in vitro resistance evolution dynamics, and mechanisms of resistance to imipenem and imipenem/relebactam in carbapenem-susceptible Klebsiella pneumoniae isolates showing ceftazidime/avibactam resistance.
Blanco-Martín T, González-Pinto L, Aja-Macaya P, Rodríguez-Pallares S, Sánchez-Peña L, Gato E, Fernández-López MdC, Outeda-García M, Rodríguez-Coello A, Pedraza-Merino R, Alonso-García I, Vázquez-Ucha JC, Martínez-Martínez L, Arca-Suárez J, Beceiro A, Bou G. Blanco-Martín T, et al. Among authors: gonzalez pinto l. Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0112024. doi: 10.1128/aac.01120-24. Epub 2024 Nov 15. Antimicrob Agents Chemother. 2024. PMID: 39545736 Free PMC article.
In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC β-lactamase in Klebsiella aerogenes.
Rodríguez-Pallares S, Blanco-Martín T, Lence E, Aja-Macaya P, Sánchez-Peña L, González-Pinto L, Rodríguez-Mayo M, Fernández-González A, Galán-Sánchez F, Beceiro A, González-Bello C, Bou G, Arca-Suárez J. Rodríguez-Pallares S, et al. Among authors: gonzalez pinto l. Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0130724. doi: 10.1128/aac.01307-24. Epub 2024 Nov 6. Antimicrob Agents Chemother. 2024. PMID: 39503481
Assessment of the activity and mechanisms of resistance to cefiderocol and combinations of β-lactams and the novel β-lactamase inhibitors avibactam, taniborbactam, zidebactam, nacubactam, xeruborbactam, and ANT3310 in emerging double-carbapenemase-producing Enterobacterales.
Blanco-Martín T, López-Hernández I, Aracil B, González-Pinto L, Aja-Macaya P, Alonso-García I, Rodríguez-Pallares S, Sánchez-Peña L, Outeda-García M, Pérez-Vázquez M, Vázquez-Ucha JC, Beceiro A, Pascual Á, Bou G, López-Cerero L, Oteo-Iglesias J, Arca-Suárez J; GEMARA-SEIMC/CIBERINFEC Study Group on the activity and resistance mechanisms to new β-lactams and β-lactamase inhibitors (PROTECT). Blanco-Martín T, et al. Among authors: gonzalez pinto l. Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0092424. doi: 10.1128/aac.00924-24. Epub 2024 Oct 9. Antimicrob Agents Chemother. 2024. PMID: 39382274
Impact of transferable β-lactamases and intrinsic AmpC amino acid substitutions on the activity of cefiderocol against wild-type and iron uptake-deficient mutants of Pseudomonas aeruginosa.
González-Pinto L, Blanco-Martín T, Alonso-García I, Rodríguez-Pallares S, Outeda-García M, Gomis-Font MA, Fraile-Ribot PA, Vázquez-Ucha JC, González-Bello C, Beceiro A, Oliver A, Bou G, Arca-Suárez J. González-Pinto L, et al. J Antimicrob Chemother. 2024 Nov 4;79(11):3023-3028. doi: 10.1093/jac/dkae326. J Antimicrob Chemother. 2024. PMID: 39287983
Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa.
González-Pinto L, Alonso-García I, Blanco-Martín T, Camacho-Zamora P, Fraile-Ribot PA, Outeda-García M, Lasarte-Monterrubio C, Guijarro-Sánchez P, Maceiras R, Moya B, Juan C, Vázquez-Ucha JC, Beceiro A, Oliver A, Bou G, Arca-Suárez J. González-Pinto L, et al. J Antimicrob Chemother. 2024 Oct 1;79(10):2591-2597. doi: 10.1093/jac/dkae263. J Antimicrob Chemother. 2024. PMID: 39073766 Free PMC article.
Corrigendum to "Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions" [International Journal of Antimicrobial Agents Volume 63, Issue 5 (2024) 107150].
Blanco-Martín T, Alonso-García I, González-Pinto L, Outeda-García M, Guijarro-Sánchez P, López-Hernández I, Pérez-Vázquez M, Aracil B, López-Cerero L, Fraile-Ribot P, Oliver A, Vázquez-Ucha JC, Beceiro A, Bou G, Arca-Suárez J; GEMARA/SEIMC-CIBERINFEC Study Group on the activity and resistance mechanisms to new β-lactams and β-lactamase inhibitors (PROTECT). Blanco-Martín T, et al. Among authors: gonzalez pinto l. Int J Antimicrob Agents. 2024 Aug;64(2):107264. doi: 10.1016/j.ijantimicag.2024.107264. Epub 2024 Jul 8. Int J Antimicrob Agents. 2024. PMID: 38981815 Free article. No abstract available.
Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study.
Lasarte-Monterrubio C, Guijarro-Sánchez P, Alonso-Garcia I, Outeda M, Maceiras R, González-Pinto L, Martínez-Guitián M, Fernández-Lozano C, Vázquez-Ucha JC, Bou G, Arca-Suárez J, Beceiro A. Lasarte-Monterrubio C, et al. Among authors: gonzalez pinto l. Euro Surveill. 2024 Apr;29(15):2300352. doi: 10.2807/1560-7917.ES.2024.29.15.2300352. Euro Surveill. 2024. PMID: 38606569 Free PMC article.
Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions.
Blanco-Martín T, Alonso-García I, González-Pinto L, Outeda-García M, Guijarro-Sánchez P, López-Hernández I, Pérez-Vázquez M, Aracil B, López-Cerero L, Fraile-Ribot P, Oliver A, Vázquez-Ucha JC, Beceiro A, Bou G, Arca-Suárez J; GEMARA/SEIMC-CIBERINFEC Study Group on the activity and resistance mechanisms to new β-lactams and β-lactamase inhibitors (PROTECT). Blanco-Martín T, et al. Among authors: gonzalez pinto l. Int J Antimicrob Agents. 2024 May;63(5):107150. doi: 10.1016/j.ijantimicag.2024.107150. Epub 2024 Mar 19. Int J Antimicrob Agents. 2024. PMID: 38513748 Free article.
12 results